{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:20:17Z","timestamp":1767180017085,"version":"build-2238731810"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T00:00:00Z","timestamp":1515110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0190525","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T14:03:01Z","timestamp":1515160981000},"page":"e0190525","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-1853","authenticated-orcid":true,"given":"Andrzej","family":"Lange","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Jaskula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janusz","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Dworacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Simiczyjew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Mordak-Domagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariola","family":"Sedzimirska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/ajh.24140","article-title":"Improvement in clinical outcome of FLT3 ITD mutated acute myeloid leukemia patients over the last one and a half decade","volume":"90","author":"T Badar","year":"2015","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3390\/jcm4040665","article-title":"Current Approaches in the Treatment of Relapsed and Refractory Acute Myeloid Leukemia","volume":"4","author":"N Ramos","year":"2015","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"S Wilhelm","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1080\/10428190802510349","article-title":"Potential role of sorafenib in the treatment of acute myeloid leukemia","volume":"49","author":"S Mori","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10428190903470893","article-title":"Sorafenib\u2013a small molecule with big promise?","volume":"51","author":"T Tadmor","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"F Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4081\/oncol.2012.e8","article-title":"An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: Biology and treatment","volume":"6","author":"T Grafone","year":"2012","journal-title":"Oncol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/imm.12162","article-title":"The mTOR pathway and integrating immune regulation","volume":"140","author":"SP Cobbold","year":"2013","journal-title":"Immunology"},{"key":"ref9","first-page":"20","article-title":"Role of PI3K\/Akt signaling in memory CD8 T cell differentiation","volume":"4","author":"EH Kim","year":"2013","journal-title":"Front Immunol. Frontiers"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","article-title":"The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications","volume":"67","author":"T Weichhart","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)","volume":"169","author":"DA Murphy","year":"2006","journal-title":"Am J Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2011.36.9868","article-title":"Impact of FLT3 internal tandem duplication on the outcome of related and unrelated hematopoietic transplantation for adult acute myeloid leukemia in first remission: a retrospective analysis","volume":"30","author":"S Brunet","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/ajh.23404","article-title":"Acute myeloid leukemia: 2013 update on risk-stratification and management","volume":"88","author":"EH Estey","year":"2013","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/bmt.2009.300","article-title":"Management of relapse after allo-SCT for AML and the role of second transplantation","volume":"44","author":"BN Savani","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"ref15","first-page":"2858","article-title":"Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantation","volume":"116","author":"H Yokoyama","year":"2010","journal-title":"Blood. American Society of Hematology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.bbmt.2014.09.007","article-title":"Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia","volume":"20","author":"Y-B Chen","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/bmt.2016.251","article-title":"Inhibition of FLT3 in AML: a focus on sorafenib","volume":"52","author":"A Antar","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-04-1552","article-title":"Risk assessment in patients with acute myeloid leukemia and a normal karyotype","volume":"11","author":"M Bienz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1182\/blood-2005-05-2174","article-title":"Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype","volume":"106","author":"N Boissel","year":"2005","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bmt.1705198","article-title":"Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood","volume":"37","author":"D Dlubek","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1038\/sj.bmt.1702633","article-title":"Apoptosis of keratinocytes is associated with infiltration of CD8+lymphocytes and accumulation of Ki67 antigen","volume":"26","author":"A Klimczak","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1073\/pnas.76.9.4350","article-title":"Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications","volume":"76","author":"H Towbin","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1016\/j.transproceed.2010.07.027","article-title":"Tarnowska a, Lange a. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation","volume":"42","author":"E Jaskula","year":"2010","journal-title":"Transplant Proc"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Y Jiang","year":"2015","journal-title":"Cell Death Dis"},{"key":"ref26","article-title":"Method for predicting response to vegf targeted therapeutics [Internet]","author":"LM Pfeffer","year":"2016","journal-title":"Google Patents"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"41274","DOI":"10.18632\/oncotarget.8978","article-title":"Sorafenib-resistant hepatocellular carcinoma stratified by phosphorylated ERK activates PD-1 immune checkpoint","volume":"7","author":"J Chen","year":"2016","journal-title":"Oncotarget. Impact Journals"},{"key":"ref28","article-title":"Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells","author":"T Motoshima","year":"2015","journal-title":"Oncol Rep"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ni.1884","article-title":"Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells","volume":"11","author":"W Ouyang","year":"2010","journal-title":"Nat Immunol. Nature Research"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-Rag Complex Targets mTORC1 to the Lysosomal Surface and Is Necessary for Its Activation by Amino Acids","volume":"141","author":"Y Sancak","year":"2010","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nature12297","article-title":"mTORC1 couples immune signals and metabolic programming to establish Treg-cell function","volume":"499","author":"H Zeng","year":"2013","journal-title":"Nature"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"4147","DOI":"10.1182\/blood.V99.11.4147","article-title":"Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth","volume":"99","author":"PO Iversen","year":"2002","journal-title":"Blood"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.intimp.2010.07.002","article-title":"The multikinase inhibitor Sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE2 in murine macrophages","volume":"10","author":"JP Edwards","year":"2010","journal-title":"Int Immunopharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3389\/fonc.2014.00349","article-title":"Myeloid-derived suppressor cells as therapeutic target in hematological malignancies","volume":"4","author":"K De Veirman","year":"2014","journal-title":"Front Oncol"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0209108","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T00:00:00Z","timestamp":1544054400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0190525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T16:49:46Z","timestamp":1540226986000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0190525"}},"subtitle":[],"editor":[{"given":"Graca D.","family":"Almeida-Porada","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0190525","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}